Possible case of deer-to-human SARS-CoV-2 transmission
On Mar. 3, 2022, a study carried out in southwestern Ontario identified a highly mutated variant of SARS-CoV-2…
-
-
Agriculture | Biotechnology | Diagnostics | Disease | Infectious Disease | Influenza | Therapeutics | USDA | Vaccine
Iowa Department of Agriculture and USDA Confirm Case of Highly Pathogenic Avian Influenza in Non-Commercial Backyard Flock
On Mar. 2, 2022, the Iowa Department of Agriculture and Land Stewardship and the United States Department of…
-
Biotechnology | COVID-19 | FDA | Therapeutics
Sorrento announced FDA authorization to proceed with phase 1 study of Intranasal STI-9199 against Covid-19 viruses
On Mar. 2, 2022, Sorrento Therapeutics announced that its Phase I study of intranasal (IN) STI-9199 (COVISHIELDTM IN) has…
-
Sorrento announced COVISHIELD antibody nasal drops prevent productive SARS-CoV-2 infections
On Mar. 2, 2022, Sorrento Therapeutics announced that new preclinical results demonstrated that pretreating an animal with intranasal…
-
British Columbia Officials confirm highly pathogenic avian influenza in the Pacific Flyway
On Mar. 2, 2022, British Columbia officials announced it is working to prevent highly pathogenic avian influenza from infecting…
-
Agriculture | Biotechnology | CRISPR | Genomics | USDA
Yield10 Bioscience Field Test Results Show Seed Oil Content Increase in Camelina and Canola
On Mar. 1, 2022, Yield10 Bioscience announced that 2021 field test results showed that the trait C3020 tested…
-
CDC reported effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA vaccination in preventing COVID-19 among children and adolescents
On Mar. 1, 2022, the U.S. Centers for Disease Control and Prevention (CDC) reported that two doses of Pfizer-BioNTech…
-
Biotechnology | CRISPR | Disease | Genomics | Therapeutics
U.S. patent appeal board ruled against University of California in CRISPR interference
On Feb. 28, 2022, the Patent and Trial Appeal Board of the U.S. Patent and Trademark Office (USPTO)…
-
EMA’s Committee for Medicinal Products for Human Use recommended authorization of Covid-19 vaccine in children (6-11 Years) In the EU
On Feb. 24, 2022, Moderna announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use…
-
USDA confirmed highly pathogenic Avian influenza in a non-commercial backyard flock in Michigan
On Feb. 24, 2022, the U.S. Department of Agriculture’s (USDA) Animal and Plant Health Inspection Service (APHIS) confirmed…
-
Medicago and GSK announced approval by Health Canada of COVIFENZ, an adjuvanted plant-based COVID-19 vaccine
On Feb. 24, 2022, Medicago and GlaxoSmithKline announced that Health Canada had granted approval for COVIFENZ, COVID-19 vaccine,…
-
Novavax announced extended durability of protection against infection and disease in UK COVID-19 vaccine phase 3 clinical Trial
On Feb. 24, 2022, Novavax shared extended analysis from its pivotal Phase 3 clinical trial conducted in the…
-
University of Oxford researchers created largest ever human family tree
On Feb. 24, 2022, researchers from the University of Oxford have used data from UK Biobank participants to…
-
Moderna and Thermo Fisher Scientific announced long-term strategic collaboration
On Feb. 23, 2022, Moderna and Thermo Fisher Scientific announced a 15-year strategic collaboration agreement to enable dedicated…
-
Novavax announced shipments of COVID-19 vaccine to European Union member states
On Feb. 23, 2022, Novavax announced the first doses of Nuvaxovid COVID-19 Vaccine (recombinant, adjuvanted) had begun shipping…
-
USDA confirmed highly pathogenic Avian influenza in a commercial poultry flock in Delaware
On Feb. 23, 2022, the U.S. Department of Agriculture’s (USDA) Animal and Plant Health Inspection Service (APHIS) confirmed…
-
Biotechnology | COVID-19 | Pharmaceutical | Therapeutics | Vaccine | WHO
Sorrento announced COVISHIELD antibody strongly neutralized BA.2 Omicron sublineage virus
On Feb. 22, 2022, Sorrento Therapeutics announced that additional preclinical results demonstrate broad spectrum COVISHIELD (STI-9167) neutralizing activity…
-
Moderna expanded global footprint through commercial partnership with Adium in Latin America
On Feb. 22, 2022, Moderna announced a distribution service agreement with Adium Pharma, a leading private Latin American…
-
Blood test for Alzheimer’s highly accurate in large, international study
On Feb. 22, 2022, Washington University in St. Louis announced that a blood test developed at the University’s…
-
Biotechnology | COVID-19 | Infectious Disease | NIH | Vaccine | WHO
Novavax and Serum Institute of India announced first EUA of COVID-19 vaccine in adolescents =12 to <18 in India
On Mar. 22, 2022, Novavax and Serum Institute of India announced that the Drugs Controller General of India…
-
The University of Virginia Cancer Center Received NCI Comprehensive Designation
On Feb. 1, 2022, University of Virginia Cancer Center announced it had been awarded a Comprehensive Cancer Center…
-
USDA confirmed highly pathogenic avian influenza in non-commercial backyard flock in New York
On Feb. 19, 2022, the U.S. Department of Agriculture’s (USDA) Animal and Plant Health Inspection Service (APHIS) confirmed…
-
CDC released the 2022 recommended immunization schedules for children and adolescents, as well as for adults
On Feb. 18, 2022, the U.S. Centers for Disease Control and Prevention (CDC) released the 2022 recommended immunization…
-
Resverlogix expanded phase 2b clinical trial for COVID-19 treatment with first site in Brazil and second in Canada
On Feb. 17, 2022, Resverlogix announced that the first Brazilian site had been initiated for its Phase 2b…
-
Health Canada authorized Novavax COVID-19 vaccine
On Feb. 17, 2022, Novavax announced that Health Canada had granted authorization for Nuvaxovid COVID-19 Vaccine (Recombinant protein,…
-
Scientists pinpointed mechanisms associated with severe COVID-19 blood clotting
On Feb. 17, 2022, after studying blood samples from 244 patients hospitalized for COVID-19, a group of researchers,…
-
Therapeutic Goods Administration of Australia authorized Moderna’s Covid-19 vaccine in children (6-11 Years)
On Feb. 16, 2022, Moderna announced that the Therapeutic Goods Administration in Australia had granted provisional registration for…
-
In a first for imaging, new microscope captured details, 3D motion of molecules in liquid
On Feb. 16, 2022, the McKelvey School of Engineering at Washington University in St. Louis, announced the lab of…
-
European Medicines Agency approved Pfizer’s 20-valent pneumococcal conjugate vaccine
On Feb. 15, 2022, Pfizer announced that the European Medicines Agency had approved the companyﾒs 20-valent pneumococcal conjugate…
-
Researchers documented third known case of HIV remission involving stem cell transplant
On Feb. 15, 2022, a woman with HIV who received a cord blood stem cell transplant to treat…
